HIGHLIGHTS
- who: Mingke Song from the Department of Pharmacology and Chemical Biology, Institute of Medical Sciences, Shanghai Jiao Tong University have published the paper: The Asparaginyl Endopeptidase Legumain: An Emerging Therapeutic Target and Potential Biomarker for Alzheimeru2019s Disease, in the Journal: (JOURNAL) of 12/08/2022
- what: The preclinical or early stage of AD has become an important research focus in the area because it offer a chance for early diagnosis and timely intervention to arrest disease progression. For the first time, the work provided a proof of concept that the imaging assessment of brain AEP . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.